Overview
- Digital biomarkers are quantifiable parameters of patients that enable computer-aided targeted diagnostics and personalized medicine.
- We develop AI tools to analyze pathology images and develop novel biomarkers in an experienced team with diverse scientific, clinical, and technical expertise.
- We collaborate with a wide network of clinical, industry and academic partners in joint research and contract R&D projects in biomarker research and digital pathology.
- Our software solutions aid in disease diagnostics, reducing the workload of pathologists, enabling more effective treatment, and ultimately reducing healthcare costs.
- We support the entire development cycle comprising exploratory scientific research, development of usable prototypical software tools, and translation into marketable IVDs.